Tratamientos sin cirugía

Experimental Study of Muscular Injury Repair with Electrolysis – USGET (ENG)

LinkedIn Whatsapp


Abat F, et al.

© 2015 Abat et al.; licensee BioMed Central


Soft tissue injuries are recurrent in sports and have an incidence rate of some 30% [1]. An overly conservative therapeutic approach conflicts with patients’ economics interests and the ability to practice their chosen sport. Some authors have proposed qualitative and histopathological classifications of muscle injuries directly related to the appearance of the lesion and its evolution [2].

The inflammatory process is one of the most important parts of the immune system’s response to injury. It is due to the fact that the biochemical mechanism and the signal cascade are consistent and durable, independent of the underlying cause of the wound [3]. Non-muscle cells such as leukocytes, phagocytes, macrophages, cytokines or growth factors play an important role in the inflammatory process in terms of recovery and regeneration following injury to the muscle as well as in the secondary damage that occurs during the inflammatory process. Certain substances, such as interleukin 1-β (IL-1β), released from the muscle injury act as intercellular messengers, start the process of inflammation and re- pair [4]. Moreover, tumor necrosis factor-alpha (TNF-α) is an important mediator of the inflammatory response after injury [5] whereas activation of PPAR, an anti- inflammatory protein, suppresses pro-inflammatory processes [6,7]. As a result of muscle injury, localized vasodilatation induced by two mechanisms comes about through the release of histamines from the cells present within the damaged area and by activating the route of the vascular endothelial growth factor and nitric oxide (VEGF-NO) [8]. VEGF is the most important capillary growth factor in skeletal muscle [7] and is essential to basal capillarization in the tissue and increased capillary growth in response to different mechanical stimuli [9].

Electrical stimulations are likely to serve as an integra- tor to organize cells into structured tissues in wound healing, development and tissues regeneration. Because cells possess signaling systems that make for electric stimulation, the exogenous application of therapeutic cur- rents for wound healing is considered to have effects as well. The difficulties lie in the technical details such as types of electrodes, stimulation parameters, stimulation position, and the variability of intrinsic resistance [10].

The USGET is an ultrasound guided physiotherapeutic and medical technique that consists in causing, by means of a galvanic current transmitted through an acupuncture needle, localized lysis in the damaged and/or degenerated tissue [11-13]. The application of a galvanic current brings about a chemical reaction, which causes the dissociation of molecules of sodium chloride and water. This process results in the formation of molecules of sodium hydroxide, which cause the destruction of the dam- aged tissue and activate the inflammatory repair response. The application of USGET can stimulate the inflammatory response and promote wound healing in degenerated patellar tendon in rats [11] and has proven effective in the treatment of chronic patellar tendinopathy [12,13].

Currently there is no published basic research relative to the effect on muscle tissue injury upon applying this treatment. Accordingly, the objective of this study was to determine whether the application of USGET therapy could have a beneficial effect on damaged muscle. An experimental design was carried out with the USGET treatment after 7 days of Notexin-induced injury. Notexin has been described as inducing necrosis of skeletal muscle fibers in experimental inflammation models. Notexin, a presynaptic phospholipase A2 neurotoxin isolated from snake venom, produced inflammatory events associated with enzymatic activity and the re- lease of arachidonic acid metabolites or mechanism related to phospholipid hydrolysis [14].
The experimental hypothesis is that the application of intratissue percutaneous electrolysis therapy after Notexina induced muscle damage causes muscular effects that may be conducive to the recovery of injured muscle tissue.


Twenty-four Sprague-Dawley rats weighing 250-300g were divided into four groups. To induce muscle injury, 200 μl of Notexin was injected intramuscularly at a con- centration of 10 μg/ml in the quadriceps of the left extremity, causing total degeneration of the muscle. As control, a group of rats (n = 6) were injected with 200 μl of saline solution. At seven days, rats were sacrificed and samples were obtained to determine the effects of Notexin-induced muscle injury. To study the effects of USGET on tissue injury, a USGET device was used. The following protocol was performed: on day seven of Notexin-induced muscle injury, one group of rats (n = 6) were treated with USGET. This treatment consists in the application of a continuous current of 4 pulses at an intensity of 3 mA for 5 seconds conveyed to the muscle. As an electrode, an acupuncture needle with a diameter of 0.32 mm was used. To study how the in- jury evolves without receiving USGET treatment, another group of rats (n = 6) was maintained dover 14 days after Notexin-induced injury. Previous to each treatment, rats were anesthetized intraperitoneally with sodium pentobarbital (90 mg/kg). The evolution of the muscle tissue injury was assessed by means of ultrasound images. The same evaluations were carried out after seven days of USGET treatment. After the protocol, rats were sacrificed and muscle tissue was removed from the treatment area and samples were analyzed by using Western blot. Additionally, blood samples were collected to detect TNF-α and IL-1β cytokines plasma levels with ELISA. The Ethical Committee of the University of Medicine of Valencia, Spain (A1301314899794) approved the study. All animal procedures were carried out in accordance with the European legislation on the use and care of laboratory animals (CEE 86/609).

Ultrasonography was performed before and after USGET to follow up on the muscle tissue injury induced by Notexin. This examination was performed according to the protocol previously described [15].

Figure. Comparison control tissue (A), muscle tissue 21 days after injury induction with Notexina (B) and the effect of the application of USGET from7 days of the induced lesion (C) in ultrasound imaging (US). It is possible to observe the area of disruption in the middle portion of the quadriceps muscle of rats from 21 days of the induced lesion (surrounded area), compared to normal tissue from the same area (B). Image (C) shows an area of less disruption in the same muscle portion treated with USGET from 21 days after induction of injury (surrounded area).


Plasma levels of cytokines IL-1β and tumor necrosis factor-α (TNF-α) were determined with ELISA kits (Thermo Scientific Laboratories, Rockford, USA) following manufactorer’s recommendations.

Muscle tissues were homogenized in a lysis buffer of (in mM) 50 Tris-HCl, 125 NaCl, 1 EDTA, 1 EGTA and 1% Nonidet (NP-40 containing 5% Complete Mini-tab cocktail proteinase inhibitor (Roche Biochemicals). It was then centrifuged at 10000 rpm for 15 min at 4°C. The protein concentration was determined using a modified Lowry method. Protein was resolved in 12% SDS-PAGE and electrophoretically transferred onto a PVDF-membrane using a Mini Trans-Blot cell (BioRad laboratories, California). Membranes were put in blocks in 5% skim milk for 1 hour at room temperature and then incubated with the corresponding antibodies following the manufacturer’s recommendations. After washing, the membranes were incubated with horseradish peroxidase- conjugated secondary antibody (Sigma Aldrich). The blots were then visualized using an Inmunostar TM HRP Substrate Kit (BioRad), again, in accordance with manufacturer’s instructions. The relative densities of the bands were analyzed using Image Gauge v4.0, Fujifilm. The proteins were normalized with tubulin. Monoclonal anti-vascular endothelial growth factor (VEGF) (1:500), anti-vascular endothelial growth factor receptor 1 (VEGF-R1) (1:500), anti-PPAR-γ (1:500) and anti-tubulin (1:1000) were used.

For statistical analysis, data are expressed as mean± standard deviation (SD). An analysis of variance (ANOVA factor) was performed to analyze the relationships within and between variables. Post-Hoc and Dunnet tests were also done to compare the different groups with the control group and the Scheffe test was used to compare all groups. A probability value of less than 0.05 was considered significant.


Notexin produced tissue injury characterized as an anechoic ultrasound image with fluid collection corresponding to a muscle lesion. Treatment with USGET produced resorption of the fluid and repair without scar tissue thickening.

Figure. Longitudinal ultrasound images of left rat quadriceps. After 7 days treated with Notexin (A), an anechoic image with fluid collection (arrow) indicating muscle lesion was observed. After EPI® treatment (B) a complete resorption of the haematoma with muscle repair (arrow) can be seen.


The levels of TNF-α and IL-1β pro-inflammatory factors in Notexin injured rats showed a significant increase (p < 0.05) in plasma concentration relative to the control. In addition, a significant decrease in the concentration of TNF-α and IL-1β was observed when the Notexin + EPI group and the Notexin group (p < 0.05) were compared. So, the application of the USGET treatment after Notexin pro- voked the decrease of both TNF-α and IL-1β to control levels (Figure 3A and B). After 14 days of Notexin treatment without USGET application, the values of cytokines continued increased. These results rule out spontaneous recovery of the muscle damage.

Figure . Plasma levels of IL-1β (A) and TNF-α (B) in control (C), Notexin (N7d, N14 d) and Notexin + EPI (N + E) groups. Values were measured by ELISA assay as indicated in methods. Data are mean ± SD of six independent experiments. *p < 0.05 vs control group; # p < 0.05 vs both Notexin groups.


Similarly, Notexin-induced injury decreases PPAR-γ expression values (p < 0.05) in rat quadriceps muscle. The application of USGET increased PPAR-γ expression and were returned to the values of the control, showing that USGET treatment produces an improvement in anti- inflammatory PPAR-γ protein (Figure 4). Furthermore, at 14 days of Notexin treatment without USGET application, PPAR-γ protein expression remains decreased, thus indicating that an increase in PPAR-γ protein expression is not spontaneous but due to the USGET treatment.


Figure.  PPAR-γ protein expression (relative densitometric units) in control (C), Notexin (N7d, N14 d) and Notexin + USGET (N+E) groups. Values were determined in left rat quadriceps muscles by Western blot. A representative inmunoblot is shown and tubulin was used as control amount of protein. Data are mean ± SD of six independent experiments. *p < 0.05 vs control group; # p < 0.05 vs both Notexin groups.


Notexin (7 and 14 days) treatment produced an increase in both VEGF and VEGF-R1 protein expression compared with the control (p < 0.05). Furthermore, USGET treatment significantly potentiated the increase in VEGF and VEGF-R1 protein expression induced by Notexin. No adverse events were presented during the study.

Figure. Analysis of VEGF and VEGF-R1 proteins. VEGF (A) and VEGF-R1 (B) protein expression in control (C), Notexin (N7d, N14 d) and Notexin + USGET (N + E) groups were determined by Western blot. Values were determined in left rat quadriceps muscles. In each panel, a representative inmunoblot is shown and tubulin was used as control amount of protein. Data are mean ± SD of six independent experiments. *p < 0.05 vs control group; # p < 0.05 vs both Notexin groups.



The main findings of this study is that USGET applied after Notexin-induced muscle injury in rats decreases the production of the inflammatory mediators TNF-α and IL- 1β, increases the protein expression of anti-inflammatory factor PPAR-γ and the angiogenic involved proteins VEGF and VEGF-R1.
An increase in the TNF-α plasma levels was described in the first days of tissular injury [16,17] and remained elevated due to its action on cellular necrosis [18]. TNF- α disrupts the differentiation process and can promote cell catabolism thereby accelerating protein degradation [5]. Furthermore, TNF-α inhibits myogenesis through redox-dependent and independent pathways [19].
One potential mechanism by which TNF-α might directly stimulate catabolism is by inhibiting myoblast differentiation, an action that might limit the regenerative response of satellite cells to muscle injury [5]. A second mechanism, apoptosis, appears less important. The third mechanism consists in a direct catabolic effect on muscle tissue. In a muscular cell culture, TNF-α directly decreases total muscle protein and the loss of muscle- specific proteins, including adult fast-type myosin heavy chain [5,19].

Our data shows an increase in the plasma level of TNF-α due to Notexin-induced injury. USGET treatment normalized the levels of TNF-α to reach control group values. By contrast, in the group of rats without USGET, the TNF-α levels remained elevated with respect to the control group at 14 days after application.

TNF-α action is also sensitive to other ligand/receptor interactions (e.g. interleukin-1 and interleukin-6). Notexin caused a significant increase of IL-1β compared to the control group. The maintenance of IL-1β over time has been associated with its condition as a pro-inflammatory cytokine more than for its action on tissue necrosis [16].

Furthermore, IL-1β induces inhibition of protein synthesis in skeletal muscle [20]. USGET returns IL-1β plasma levels to normal values. On the contrary, after 14 days of application without USGET, the levels of IL-1β remain significantly high compared to control values. Taken together, the results indicate that USGET is effective in diminishing pro-inflammatory mediators. Further studies are needs to determine the mechanisms involved in the inflammatory effects of USGET. Besides that, USGET decreases pro- inflammatory mediators and anti-inflammatory proteins may also be activated. PPAR-γ has been recognized as playing a fundamental role in the immune response through its ability to decrease the expression of pro-inflammatory genes [21]. It also increases the expression levels of genes that are involved in anti-inflammatory effects and tissue repair [22,23]. Furthermore, PPAR-γ induces the expression of VEGF and its receptors in cultured cardiac myofibroblasts [24]. Our data indicated that Notexin produced a significant decrease in PPAR-γ protein expression, similar at 7 and 14 days, compared with control. USGET significantly increases PPAR-γ protein expression reduced by Notexin and returns levels to control values. In addition, PPAR-γ promotes the myocellular storage of energy by increasing fatty acid uptake and esterification while simultaneously enhancing insulin signaling and glycogen formation, which have beneficial effects on metabolic health and therefore on tissue repair [25].

Electrical stimulation has multiple effects in directing cell division, vascular endothelial cells, angiogenesis and endothelial migration, all of which are important elements in wound healing [10]. Vascular endothelial growth factor (VEGF) is a paracrine factor. Its main function is to promote angiogenesis by improving cellular survival, inducing proliferation and enhancing the migration and invasion of endothelial cells. Skeletal muscle fibers can control capillary growth by releasing VEGF from intracellular vesicles during contraction [26]. Recent evidence suggests that VEGF has effects on skeletal muscle regeneration by stimulating the myogenic differentiation of muscle-derived stem cells [27,28].

Our results indicate a clear induction of VEGF protein expression after Notexin-induced damage. These results are in accordance with a greater production of VEGF in damaged tissue than in normal tissue [29]. Furthermore, VEGF-R1, the more actively induced receptor by tissue injury, is also increased as has been described in trauma patients [30]. USGET treatment further significantly increases both VEGF and VEGF-R1 thus suggesting an active role in maintaining blood flow in the microcirculation and also may increase the systemic level of soluble anti-inflammatory and cytoprotective mediator events that can improve the recovery from injury [30].

Despite the many treatments proposed to treat muscle injuries, the rate of re-injury is still very high. This is probably due to the fact that a greater understanding and analysis of the type, size and location of the lesion in each case [31] is required.
Some authors argue that the size of the lesion correlates with the time the patient will need to return to competition [32]. By contrast, other study groups suggest that neither the presence of ultrasound findings nor the size of them correlate with the time needed to return to competition. Thus, the prognosis for muscular injuries should not be guided by these results alone [33,34].

Although the number of cases may be considered low, the difference between the variables studied was very high. Therefore, sufficient power was obtained so as to detect differences with a significance ranging from 55 to 58% for VEGF and VEGF-R1 variables as well as from 88% to 100% in TNF and IL-1B variables.

The work has some limitations such as the use of rats. As such, it might not be possible to extrapolate the result to humans. In spite of that possibility, rats have been used in many valid experimental studies [14-17,20,27]. Another limitation is the lack of a histological or functional evaluation, which could give physiological relevance to the interpretation of the data presented [35]. The electrolysis and/or sodium hydroxide produced by the USGET may interfere with IL-1beta and TNF-alpha values, affecting the existing cytokines. Therefore, we wait 7 days after the USGET application to see its beneficial effects. Cytokines from the cells at the local position will be produced chronically and maintained over time when inflammation and damage is present. We detect a reduction of pro-inflammatory cytokines after EPI induction. Thus, cells are probably in a state of less inflammation with less cytokine production in comparison to cells without the USGET.
Despite the limitations exposed, the present work is the first investigation on the effect of USGET on muscle tis- sue that shows the biomolecular mechanisms triggered by the application of the same. This experimental work is the basis upon which clinical trials to confirm the effectiveness of the USGET in humans should be developed.


The application of USGET on rat muscle previously injured with Notexin causes a significant decrease in pro-inflammatory mediators like TNF-α as well as IL-1β levels. On the other hand, the application of USGET produced an increase in the expression of anti- inflammatory proteins (PPAR-γ) and also increases VEGF and VEGF-R1 expression. Therefore, the use of USGET may affect inflammatory mediators in damaged muscle tissue and influence the new vascularization of the injured area. These results suggest that USGET might represent a useful new therapy for the treatment of muscle injuries.
Although our study in rats may represent a valid approach to evaluate USGET, studies designed to determine how USGET may affect recovery of injury in humans are needed.


Ekstrand J, Hägglund M, Waldén M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011;39(6):1226–32.

Verrall GM, Slavotinek JP, Barnes PG. The effect of sports specific training on reducing the incidence of hamstring injuries in professional Australian rules football players. Br J Sports Med. 2005;39(6):363–8.

Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004;164(3):1007–19.

Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288(2):R345–53.

Moresi V, Pristerà A, Scicchitano BM, Molinaro M, Teodori L, Sassoon D, et al. Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem Cells. 2008;26(4):997–1008.

Liu CS, Chang CC, Du YC, Chang FR, Wu YC, Chang WC, et al. 2-hydroxy-4′- methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma. J Cardiovasc Pharmacol. 2012;59(4):339–51.

Thom R, Rowe GC, Jang C, Safdar A, Arany Z. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor γ coactivator (PGC)-1α. J Biol Chem. 2014;289(13):8810–7.

Hudlicka O, Brown MD. Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res. 2009;46(5):504–12.

Olfert IM, Howlett RA, Wagner PD, Breen EC. Myocyte vascular endotelial growth factor is required for exercise-induced skeletal muscle angiogenesis. Am J Physiol Regul Integr Comp Physiol. 2010;299(4):R1059–67.

Zhao M. Electrical fields in wound healing-An overriding signal that directs cell migration. Semin Cell Dev Biol. 2009;20(6):674–82.

Abat F, Valles SL, Gelber PE, Polidori F, Stitik TP, García-Herreros S, et al. Molecular repair mechanisms using the Intratissue Percutaneous Electrolysis technique in patellar tendonitis. Rev Esp Cir Ortop Traumatol. 2014;58(4):201–5.

Abat F, Gelber PE, Polidori F, Monllau JC, Sanchez-Ibañez JM. Clinical results after ultrasound-guided intratissue percutaneous electrolysis and eccentric exercise in the treatment of patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2014;23(4):1046–52.

Abat F, Diesel WJ, Gelber PE, Polidori F, Monllau JC, Sanchez-Ibañez JM. Effectiveness of the Intratissue Percutaneous Electrolysis technique and isoinertial eccentric exercise in the treatment of patellar tendinopathy at two years follow-up. Muscles Ligaments Tendons J. 2014;4(2):188–93.

Head SI, Houweling PJ, Chan S, Chen G, Hardeman EC. Properties of regenerated mouse extensor digitorum longus muscle following notexin injury. Exp Physiol. 2014;99(4):664–74.

Joensen J, Gjerdet NR, Hummelsund S, Iversen V, Lopes-Martins RA, Bjordal JM. An experimental study of low-level laser therapy in rat Achilles tendon injury. Lasers Med Sci. 2012;27(1):103–11.

Meador BM, Krzyszton CP, Johnson RW, Huey KA. Effects of IL-10 and age on IL-6, IL-1beta, and TNF-alpha responses in mouse skeletal and cardiac muscle to an acute inflammatory insult. J Appl Physiol. 2008;104(4):991–7.

Crassous B, Richard-Bulteau H, Deldicque L, Serrurier B, Pasdeloup M, Francaux M, et al. Lack of effects of creatine on the regeneration of soleus muscle after injury in rats. Med Sci Sports Exerc. 2009;41(9):1761–9.

Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A. Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One. 2010;12;5(10):e13262.

Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol. 2002;283(3):C714–21.

Borghi SM, Zarpelon AC, Pinho-Ribeiro FA, Cardoso RD, Cunha TM, Alves-Filho JC, et al. Targeting interleukin-1β reduces intense acute swimming-induced muscle mechanical hyperalgesia in mice. J Pharm Pharmacol. 2014;66(7):1009–20.

Bertin B, Dubuquoy L, Colombel JF, Desreumaux P. PPAR-gamma in ulcerative colitis: a novel target for intervention. Curr Drug Targets. 2013;14(12):1501–7.

von Knethen A, Neb H, Morbitzer V, Schmidt MV, Kuhn AM, Kuchler L, et al. PPARγ stabilizes HO-1 mRNA in monocytes/macrophages which affects IFN-β expression. Free Radic Biol Med. 2011;51(2):396–405.

Lea S, Plumb J, Metcalfe H, Spicer D, Woodman P, Fox JC, et al. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. Eur Respir J. 2014;43(2):409–20.

Chintalgattu V, Harris GS, Akula SM, Katwa LC. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc Res. 2007;74(1):140–50.

Hu S, Yao J, Howe AA, Menke BM, Sivitz WI, Spector AA, et al. Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle. Mol Endocrinol. 2012;26(6):977–88.

Hoier B, Prats C, Qvortrup K, Pilegaard H, Bangsbo J, Hellsten Y. Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle. FASEB J. 2013;27(9):3496–504.

Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther. 2008;15(6):404–14.

Beckman SA, Chen WC, Tang Y, Proto JD, Mlakar L, Wang B, et al. Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2013;33(8):2004–12.